|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| OPERATING ACTIVITIES | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operations: | |||||
| Depreciation and net amortization | |||||
| Securities premium amortization (discount accretion), net | |||||
| Loan (discount accretion) premium amortization, net | |||||
| Provision for (reversal of) credit losses | |||||
| Stock compensation expense | |||||
| Deferred tax expense (benefit) | |||||
| Net (gain) loss on sale of AFS securities | |||||
| Net gain on sale of equity securities | |||||
| Loss on impairment of investments | |||||
| Net loss on premises and equipment | |||||
| Gross proceeds from sales of loans held for sale | |||||
| Gross originations of loans held for sale | |||||
| Net (gain) loss on consumer receivables | |||||
| Net (gain) loss on OREO | |||||
| (Gain on purchase) loss on redemption of subordinated notes | |||||
| Net change in: | |||||
| Interest receivable | |||||
| Other assets | |||||
| Interest payable | |||||
| Other liabilities | |||||
| Net cash provided by (used in) operating activities | |||||
| INVESTING ACTIVITIES: | |||||
| Securities AFS: | |||||
| Purchases | |||||
| Sales | |||||
| Maturities, calls and principal repayments | |||||
| Securities HTM: | |||||
| Purchases | |||||
| Maturities, calls and principal repayments | |||||
| Proceeds from sales of equity securities | |||||
| Proceeds from redemption of FHLB stock and equity investments | |||||
| Purchases of FHLB stock and equity investments | |||||
| Net loan paydowns (originations) | |||||
| Proceeds from sales of customer receivables | |||||
| Purchases of premises and equipment | |||||
| Proceeds from (purchases of) BOLI | |||||
| Proceeds from sales of premises and equipment | |||||
| Net proceeds from sales of OREO | |||||
| Proceeds from sales of repossessed assets | |||||
| Net cash provided by (used in) investing activities | |||||
| FINANCING ACTIVITIES: | |||||
| Net change in deposits | |||||
| Net change in other borrowings | |||||
| Proceeds from FHLB borrowings | |||||
| Repayment of FHLB borrowings | |||||
| Net proceeds from issuance of subordinated notes | |||||
| Purchase/redemption of subordinated notes | |||||
| Proceeds from stock option exercises | |||||
| Cash paid to tax authority related to tax withholding on share-based awards | |||||
| Purchase of common stock | |||||
| Proceeds from the issuance of common stock for dividend reinvestment plan | |||||
| Cash dividends paid | |||||
| Net cash provided by (used in) financing activities | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| SUPPLEMENTAL DISCLOSURES FOR CASH FLOW INFORMATION: | |||||
| Interest paid | |||||
| Income taxes paid | |||||
| SUPPLEMENTAL DISCLOSURES OF NONCASH INVESTING AND FINANCING ACTIVITIES: | |||||
| Loans transferred to other repossessed assets and real estate through foreclosure | |||||
| Loans transferred from held for investment to held for sale | |||||
| Transfer of AFS to HTM securities | |||||
| Unsettled trades to purchase securities | |||||
| Unsettled issuances of brokered CDs | |||||
| Unsettled trades to repurchase common stock | |||||
Loading...